These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2987745)

  • 1. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist.
    Jolicoeur FB; Rivest R; St-Pierre S; Gagné MA; Dumais M
    Neuropeptides; 1985 Apr; 6(2):143-56. PubMed ID: 2987745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GABA compounds injected into the subpallidal regions of rat brain on nucleus accumbens evoked hyperactivity.
    Patel S; Slater P
    Behav Neurosci; 1988 Aug; 102(4):596-600. PubMed ID: 2844207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
    Kalivas PW; Nemeroff CB; Prange AJ
    Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW; Richardson-Carlson R; Duffy P
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.
    O'Neill KA; Carelli RM; Jarvis MF; Liebman JM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):739-45. PubMed ID: 2560212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin blocks certain amphetamine-induced behaviours.
    Ervin GN; Birkemo LS; Nemeroff CB; Prange AJ
    Nature; 1981 May; 291(5810):73-6. PubMed ID: 7231526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intrapallidal drugs on hyperactivity induced by nucleus accumbens dopamine receptor stimulation.
    Slater P; Longman DA; Dickinson SL
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):201-6. PubMed ID: 7155200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist.
    Patel S; Slater P; Crossman AR
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):334-40. PubMed ID: 4094623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
    Ervin GN; Nemeroff CB
    Neuropsychopharmacology; 1988 Sep; 1(3):243-50. PubMed ID: 3150806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat.
    Robledo P; Maldonado R; Koob GF
    Brain Res; 1993 Sep; 622(1-2):105-12. PubMed ID: 8242350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
    Rivest R; Jolicoeur FB; Marsden CA
    Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP.
    Arnt J
    Life Sci; 1981 Apr; 28(14):1597-603. PubMed ID: 6264256
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area.
    Kalivas PW; Taylor S
    Brain Res; 1985 Dec; 358(1-2):70-6. PubMed ID: 4075132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B; Domeney AM; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
    Morgenstern R; Fink H
    J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: possible dependence on dopaminergic mechanisms.
    Donzanti BA; Uretsky NJ
    Neuropharmacology; 1983 Aug; 22(8):971-81. PubMed ID: 6137783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.